References
- Balow JE, Iii HAA. Treatment of proliferative lupus nephritis. Am J Kidney Dis. 2004;43(2):383–385. doi:10.1053/j.ajkd.2003.12.008
- Mok CC. Prognostic factors in lupus nephritis. Lupus. 2005;14(1):39–44. doi:10.1191/0961203305lu2057oa
- Chinese lupus nephritis diagnosis and treatment guidelines compilation group. Chinese lupus nephritis diagnosis and treatment guidelines. Chin Med J. 2019;99(44):3441–3455.
- Flores-mendoza G, Sansón SP, Rodríguez-castro S, Crispín JC, Rosetti F. Mechanisms of tissue injury in lupus nephritis. Trends Mol Med. 2018;24(4):364–378.
- Fanouriakis A, Kostopoulou M. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713–723. doi:10.1136/annrheumdis-2020-216924
- Yu X-Q, Wei J-L. Kidney disease in china: recent progress and prospects. Chin Med J. 2009;122(17):2048–2053.
- Mei Z, Sheng-qian X, Jing C, et al. Relationship between renal pathological classifications and clinical parameters. Chin J General Pract. 2017;15(2):227–229, 242.
- Wen-hui G. Immune Index and Pathological Types of Lupus Nephritis: Analysis of 97 Patients. Changchun: Jilin University; 2014.
- Ming-hui Z, Yan-hui L, Xin-lan L, et al. Analysis of clinical and pathological of 144 patients with lupus nephritis. Guangdong Med J. 2009;30(3):453–456.
- Zhou F-D, Zhao M-H, Zou Z, et al. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre. Nephrol Dial Transplant. 2009;24(3):870–876. doi:10.1093/ndt/gfn554
- Zhi-zhen Y. The Correlation Analysis Between Clinical Score and Pathological Score in Patients with Lupus Nephritis. Changchun: Jilin University; 2018.
- Kun J. The Correlation Between Pathological Classification, Clinical Manifestation and Laboratory Diagnosis of Lupus Nephritis. Shihezi: Shihezi University; 2016.
- Zhuo-qing Q. A Case-Control Study of Clinical Feature and Prognosis of Systemic Lupus Erythematosus Patients with Anemia. Beijing: Chinese Academy of Medical Sciences; 2012.
- Xiao-yan Z, Yu Y. Clinical application of cystatin c and its detection standardization progress. Labeled Immunoassays Clin Med. 2017;24(6):717–720.
- Hanly G, Thompson K, McCurdy G, et al. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods. 2010;352(1):147–152. doi:10.1016/j.jim.2009.10.003
- Yi Z. The Analysis of Clinical Characteristics and Pathological Type in Lupus Nephritis. Shanghai: Fudan University; 2010.
- Ishizaki J, Saito K, Nawata M, et al. Low complements and high titre of anti-sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology. 2015;54(3):405–412. doi:10.1093/rheumatology/keu343